Global Famciclovir API Market Size, Share, Trends and Forecast 2022-2030

Market Analysis and Insights: Global Famciclovir API Market
Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)

Due to the COVID-19 pandemic, the global Famciclovir API market size is estimated to be worth US$ 13 million in 2022 and is forecast to a readjusted size of US$ 15 million by 2028 with a CAGR of 2.3% during the review period. Fully considering the economic change by this health crisis, Insourced accounting for % of the Famciclovir API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Tablet Product segment is altered to an % CAGR throughout this forecast period.

The classification of Famciclovir API includes Insourced and Outsourced. In addition, the proportion of Insulin Outsourced in 2019 is about 71%, and the proportion is in increasing trend from 2015 to 2020.

Famciclovir API is widely used in Tablet Product, Capsule Product and Others Product. The most proportion of Famciclovir API is used in Tablet Product, and the proportion in 2019 is about 80%.

Asia-Pacific is the largest consumption market, with a market share nearly 48% in 2019. Following Asia-Pacific, North America is the second largest consumption market with the market share of about 21%.

Market competition is intense. Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Insourced

Outsourced

Others

Segment by Application

Tablet Product

Capsule Product

Others

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Famciclovir API market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Chongqing Shenghuaxi Pharma

Aurobindo Pharma Limited

Apotex Pharmachem

Changzhou Kony Pharma Co

Teva Pharmaceutical Industries

Olon

Fuan Pharmaceutical

Zhejiang Charioteer Pharmaceutical

Jialin Pharmaceutical

Zhejiang Hisun

Hetero